首页> 外文期刊>Health Psychology Research >Improvement of health-related quality of life and psychological well-being after HCV eradication with direct-acting antiviral agents. Real life setting data of an Italian cohort valued by Hepatitis Quality of Life Questionnaire (HQLQv2)
【24h】

Improvement of health-related quality of life and psychological well-being after HCV eradication with direct-acting antiviral agents. Real life setting data of an Italian cohort valued by Hepatitis Quality of Life Questionnaire (HQLQv2)

机译:通过直接作用抗病毒药物的HCV消除后,改善健康相关的生活质量和心理幸福。通过肝炎致肝炎质量调查问卷(HQLQV2)重视意大利队列的现实生活环境

获取原文
           

摘要

HCV (Hepatitis C Virus) decreases Health-Related Quality of Life with detriments to physical, mental and social health domains. Interferon and Ribavirin treatment is associated with depression and anxiety that further impairs HRQoL (Health- Related Quality of Life). IFN-free (interferon-free) regimes (Direct Acting Antivirals, DAAs) are safe and highly effective drugs, with improvement also of HRQoL and related Psychological Well-Being. Our aim is to describe how the latest generation IFN-free treatment can change quality of life and related Psychological Well-Being in Italian Chronic Hepatitis C/Cirrhosis affected patients. SF-36v2 (Short Form Health Survey is a 36-item, patient-reported survey of patient health) – HQLQv2 (Hepatitis Quality of Life Questionnaire) was administered at two time points: baseline (n=72) and 12 weeks after the end of therapy [n=72, SVR=72 - Sustained Virologic Response (SVR)]. Patients with chronic HCV undergoing DAAs treatment from two Italian centers were enrolled. The overall average of the answers is configured for most of the domains that make up the questionnaire, with scores above 50. The quality of life of this sample is very close to the average of the US population, with a minimum average score of 45.9 for the Role Emotional scale and an average maximum score of 56.4 for the Vitality scale. Both are significant results from statistical analysis. It seems that DAAs treatment therapy does not affect but improves the general quality and psychological state of adult patients with Chronic HCV infection.
机译:HCV(丙型肝炎病毒)减少了与身体,精神和社会卫生域名的健康状生活质量。干扰素和利巴韦林治疗与进一步损害HRQOL(相关的生活质量)的抑郁和焦虑有关。自由IFN(无干扰素)制度(直接代理抗病毒,DAAS)是安全且高效的药物,也有改善HRQOL和相关的心理福祉。我们的目的是描述最新一代的IFN-治疗如何改变生活质量和相关心理福祉的意大利慢性丙型肝炎受影响的患者。 SF-36V2(短型健康调查是36项,患者报告的患者健康调查) - HQLQV2(肝炎质量问卷调查问卷)在两个时间点进行给药:基线(n = 72)和结束后12周治疗[n = 72,SVR = 72 - 持续的病毒学反应(SVR)]。患有来自两名意大利中心的慢性HCV的慢性HCV患者进行了注册。答案的总体平均值是为大多数构成调查问卷的域,分数超过50.这个样本的生活质量非常接近美国人口的平均值,最低平均得分为45.9角色情绪尺度和56.4的平均最大得分为生命量表。两者都是统计分析的显着结果。似乎DAAs治疗疗法不会影响成人慢性HCV感染患者的一般质量和心理状态。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号